Immuneering Corp Valuation
| IMRX Stock | USD 2.24 0.15 7.18% |
Based on Macroaxis valuation methodology, the firm appears to be undervalued. Immuneering Corp retains a regular Real Value of $6.5 per share. The prevalent price of the firm is $2.24. Our model calculates the value of Immuneering Corp from evaluating the firm fundamentals such as Return On Asset of -0.37, shares owned by insiders of 29.12 %, and Return On Equity of -0.62 as well as inspecting its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Immuneering Corp's valuation include:
Price Book 1.0018 | Enterprise Value 11 M | Enterprise Value Ebitda (1.53) | Price Sales 563.6155 | Enterprise Value Revenue 191.9 K |
Undervalued
Today
Please note that Immuneering Corp's price fluctuation is very risky at this time. Calculation of the real value of Immuneering Corp is based on 3 months time horizon. Increasing Immuneering Corp's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Immuneering Corp is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Immuneering Stock. However, Immuneering Corp's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.24 | Real 6.5 | Target 19.29 | Hype 2.38 |
The intrinsic value of Immuneering Corp's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Immuneering Corp's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Immuneering Corp helps investors to forecast how Immuneering stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Immuneering Corp more accurately as focusing exclusively on Immuneering Corp's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Immuneering Corp's intrinsic value based on its ongoing forecasts of Immuneering Corp's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Immuneering Corp's closest peers.
Immuneering Corp Cash |
|
Immuneering Valuation Trend
Analysing the historical paterns of Immuneering Corp's enterprise value and its market capitalization is a good way to estimate and gauge the value of Immuneering Corp over time and is usually enough for investors to make rational market timing decisions.
Immuneering Corp Total Value Analysis
Immuneering Corp is currently projected to have valuation of 11.01 M with market capitalization of 66.42 M, debt of 4.46 M, and cash on hands of 128.1 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Immuneering Corp fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
11.01 M | 66.42 M | 4.46 M | 128.1 M |
Immuneering Corp Investor Information
About 29.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.0. Some equities with similar Price to Book (P/B) outperform the market in the long run. Immuneering Corp recorded a loss per share of 1.9. The entity had not issued any dividends in recent years. Based on the analysis of Immuneering Corp's profitability, liquidity, and operating efficiency, Immuneering Corp is not in a good financial situation at this time. It has a very high odds of going through financial crisis in November.Immuneering Corp Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Immuneering Corp has an asset utilization ratio of 4.44E-4 percent. This suggests that the Company is making $4.0E-6 for each dollar of assets. An increasing asset utilization means that Immuneering Corp is more efficient with each dollar of assets it utilizes for everyday operations.Immuneering Corp Ownership Allocation
Immuneering Corp has a total of 29.65 Million outstanding shares. Immuneering Corp secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.Immuneering Corp Profitability Analysis
The company reported the previous year's revenue of 455. Net Loss for the year was (53.47 M) with profit before overhead, payroll, taxes, and interest of 158.83 K.About Immuneering Corp Valuation
Our relative valuation model uses a comparative analysis of Immuneering Corp. We calculate exposure to Immuneering Corp's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Immuneering Corp's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -764.1 K | -725.9 K | |
| Pretax Profit Margin | (183.28) | (174.11) | |
| Operating Profit Margin | (187.75) | (178.36) | |
| Net Loss | (178.81) | (169.87) | |
| Gross Profit Margin | 0.45 | 0.35 |
Immuneering Corp Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 28.4 M |
Immuneering Corp Current Valuation Indicators
Valuation refers to the process of determining the present value of Immuneering Corp and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Immuneering we look at many different elements of the entity such as Immuneering's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Immuneering Corp, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Immuneering Corp's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Immuneering Corp's worth.Additional Tools for Immuneering Stock Analysis
When running Immuneering Corp's price analysis, check to measure Immuneering Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immuneering Corp is operating at the current time. Most of Immuneering Corp's value examination focuses on studying past and present price action to predict the probability of Immuneering Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immuneering Corp's price. Additionally, you may evaluate how the addition of Immuneering Corp to your portfolios can decrease your overall portfolio volatility.